Advertisement

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells Using Sendai Virus

  • Filipa A. C. SoaresEmail author
  • Roger A. Pedersen
  • Ludovic Vallier
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1357)

Abstract

This protocol describes the efficient isolation of peripheral blood mononuclear cells from circulating blood via density gradient centrifugation and subsequent generation of integration-free human induced pluripotent stem cells. Peripheral blood mononuclear cells are cultured for 9 days to allow expansion of the erythroblast population. The erythroblasts are then used to derive human induced pluripotent stem cells using Sendai viral vectors, each expressing one of the four reprogramming factors Oct4, Sox2, Klf4, and c-Myc.

Keywords:

Reprogramming Human induced pluripotent stem cells Sendai virus Peripheral blood mononuclear cells Erythroblast 

Notes

Acknowledgements

The authors thank Dr. Thomas Moreau for expert advice and support. The authors also acknowledge the contribution of “Fundação para a Ciência e a Tecnologia” (SFRH/BD/69033/2010) and Cambridge Hospitals National Institute for Health Research Biomedical Research Center and ERC starting grant Relieve-IMDs.

References

  1. 1.
    Yang W, Mills JA, Sullivan S, Liu Y, French DL, Gadue P (2012) iPSC Reprogramming from human peripheral blood using sendai virus mediated gene transfer. In: StemBook (ed) The Stem Cell Research Community, StemBookGoogle Scholar
  2. 2.
    Chou B-K, Mali P, Huang X, Ye Z, Dowey SN, Resar LMS, Zou C, Zhang YA, Tong J, Cheng L (2011) Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 21(3):518–529PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    van den Akker E, Satchwell TJ, Pellegrin S, Daniels G, Toye AM (2010) The majority of the in vitro erythroid expansion potential resides in CD34(-)cells, outweighing the contribution of CD34(+) cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica 95(9):1594–1598PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Leberbauer C, Boulmé F, Unfried G, Huber J, Beug H, Müllner EW (2005) Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood 105(1):85–94PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Filipa A. C. Soares
    • 1
    Email author
  • Roger A. Pedersen
    • 1
  • Ludovic Vallier
    • 1
    • 2
  1. 1.Anne McLaren Laboratory for Regenerative Medicine and Department of Surgery, Wellcome Trust – Medical Research Council Cambridge Stem Cell InstituteUniversity of CambridgeCambridgeUK
  2. 2.Wellcome Trust Sanger InstituteHinxtonUK

Personalised recommendations